MATWIN ANNUAL REPORT 2019 stephanie.dhont2020-05-06T09:56:59+02:00 Partagez cette histoire, choisissez votre plate-forme ! FacebookXRedditLinkedInTumblrPinterest Related Posts Apmonia Therapeutics laureate from EIC accelerator program Apmonia Therapeutics laureate from EIC accelerator program HEPHAISTOS secures €10.3 M to reach the clinical stage HEPHAISTOS secures €10.3 M to reach the clinical stage PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial Newsletter MATWIN June 2023 Newsletter MATWIN June 2023 MATWIN – PSCC partnership – Interview Benjamin Garel MATWIN – PSCC partnership – Interview Benjamin Garel
